Wolfe Research upgraded C.H. Robinson (CHRW) to Outperform from Peer Perform with a $112 price target While the firm sees EPS risk in Q2 with weaker Forwarding results, C.H. Robinson is “one of just a handful of stocks where we’re now above consensus” in calendar 2026, the analyst tells investors. As investor focus starts to shift over the next couple of months to 2026, the valuation is attractive on both an absolute and relative basis, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHRW:
- C.H. Robinson price target raised to $120 from $115 at Susquehanna
- CH Robinson’s Strategic Positioning and Operational Improvements Drive Buy Rating Amid Market Challenges
- C.H. Robinson exec Freeman sells 5,700 shares
- C.H. Robinson price target raised to $117 from $106 at BofA
- C.H. Robinson Shareholders Approve Key Proposals at Meeting